Stock Day Media

Navidea Biopharmaceuticals, Inc. | Ekinops

Jul 10, 2024 · 0m

<div>Navidea Biopharmaceuticals, Inc. (OTC: NAVB), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced disappointing results of an exploratory analysis conducted on the company’s pivotal NAV3-33 clinical trial. Dr. Michael Blue, Navidea’s Chief Medical Officer, said "Results are not indicative of a commercially viable product.”<br> <br> Ekinops (Euronext Paris: EKI) (ISIN: FR0011466069), a leading supplier of optical transport and enterprise connectivity solutions for telecom operators and enterprises, today announced that Orange Business has chosen Ekinops …

ಈ ಘಟನೆಯನ್ನು ಇನ್ನೂ ಸಹ ಹೊರಹಾಕಲಾಗಿಲ್ಲSocket error code NotSupported

AI ಗೆ ಈ ಘಟನೆಯನ್ನು ಪರಿಶೀಲಿಸಲು STT.ai ಬಳಸಿ. ಭಾಷಣಕಾರನನ್ನು ಪತ್ತೆಹಚ್ಚಿ, ಪೌರಸ್ತ್ಯಗೊಳಿಸು ಮತ್ತು ಅನೇಕ ವಿನ್ಯಾಸಗಳನ್ನು ಉತ್ಥಾಪಿಸಿರಿ.

ಸಾ. ಶ.

ಧ್ವನಿಕಾರ (ಸರ್ವರ್) ಪತ್ತೆಹಚ್ಚುವಿಕೆ ಪದ ಹಂತಗಳುName SRT, TXT, Jಸಾನ್ ಆಗಿ ರಫ್ತುಮಾಡುName

ಇನ್ನೂ ಹೆಚ್ಚಿನ ನಂಬಿಕೆಗಳು

Navidea Biopharmaceuticals, Inc. | Ekinops

ಈ ಘಟನೆಯನ್ನು ಇನ್ನೂ ಸಹ ಹೊರಹಾಕಲಾಗಿಲ್ಲSocket error code NotSupported

ಇನ್ನೂ ಹೆಚ್ಚಿನ ನಂಬಿಕೆಗಳು

Viper Networks: Connecting the Unconnected with Innovative Solutions

Revolutionizing Investment: Mobi Card's Game-Changing Updates

Husqvarna | Delta Apparel, Inc.

Scheid Vineyards Inc. | Royal Road Minerals

Innovent Biologics, Inc. | MAX Power Mining Corp.

NuRAN Wireless Inc. | Robotic Assistance Devices, Inc.

Laredo Oil, Inc. | BlockQuarry Corp.

DEEPX | EACO Corporation

PCS Edventures!, Inc. | Right On Brands, Inc.

Q Precious and Battery Metals Corp. | Crescita Therapeutics Inc.